Sun Pharmaceuticals on Friday announced that one of its subsidiaries acquired the Uractiv portfolio from Fiterman Pharma in Romania. The portfolio of the company includes food supplements like minerals, vitamins and adjuvants; cosmetics and medical devices used for maintaining urinary tract health.
Uractiv is Romania’s No. 1 brand in its sector, with over a decade of consumer trust. Annualized revenues for the portfolio, which includes 12 SKUs, are around US$ 8.7 million*. Adults and children will benefit from the products.
“We’re thrilled to add Uractiv to our consumer healthcare offering in Romania,” says the company. This acquisition fits well with our plan to extend our non-prescription product portfolio.
Sun Pharma’s Aalok Shanghvi, EVP and Head- Generic R&D, Generic Global BD, and Emerging Markets, stated the company’s basket in Romania and neighbouring markets. “We’ve got a
Terapia has a large presence in Romania, where it is the number one generics and OTC company. “We’ll use our strong marketing and distribution capabilities to help these businesses expand even more,” he added.